Amaurosis fugax
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Transient monocular blindness
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
Overview
Amaurosis (Greek meaning darkening, dark, or obscure) is vision loss or weakness that occurs without an apparent lesion affecting the eye [2]. It may result from either a medical condition or from excess acceleration, as in flight. The term is the same as the Latin gutta serena. Amaurosis fugax (Latin fugax meaning fleeting, Greek amaurosis meaning darkening, dark, or obscure) is a transient monocular visual loss.[1] Amaurosis fugax (Latin: fugax meaning fugitive) is a temporary loss of vision in one eye caused by decreased blood flow (ischemia) to the retina. Another cause is the presence of emboli located in the ipsilateral(same side) internal carotid artery. It is a type of transient ischaemic attack (TIA). Those experiencing Amaurosis usually experience complete symptom abeyance within a few minutes.
References
- ↑ Fisher, C. “‘Transient monocular blindness’ versus ‘amaurosis fugax.'” Neurology. 1989;39(12):1622-4. PMID 2685658.
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Prior to 1990, amaurosis fugax could, “clinically, be divided into four identifiable symptom complexes, each with its underlying pathoetiology: embolic, hypoperfusion, angiospasm, and unknown.”[1] In 1990, the causes of amaurosis fugax were better refined by Amaurosis Fugax Study Group, which has defined five distinct causes of transient monocular blindness: embolic, hemodynamic, ocular, neurologic, and idiopathic.[2] Concerning the pathology underlying these causes (stay idiopathic), “some of the more frequent causes include atheromatous disease of the internal carotid or ophthalmic artery, vasospasm, optic neuropathy, giant cell arteritis, angle-closure glaucoma, increased intracranial pressure, orbital compressive disease, a steal phenomenon, and blood hyperviscosity or hypercoagulability.”[3]
Pathophysiology
Embolic and Hemodynamic Origin
With respect to embolic and hemodynamic causes, this transient monocular visual loss ultimately occurs due to a temporary reduction in retinal artery, ophthalmic artery, or ciliary artery blood flow, leading to a decrease in retinal circulation which, in turn, causes retinal hypoxia.[4] Also, it must be noted that while, classically and most commonly, emboli causing amaurosis fugax are described as coming from an atherosclerotic carotid artery, any emboli arising from vasculature preceding the retinal artery, ophthalmic artery, or ciliary arteries may cause this transient monocular blindness.
- Atherosclerotic carotid artery: Amaurosis fugax may present as a type of transient ischemic attack (TIA), during which an embolus unilaterally obstructs the lumen of the retinal artery or ophthalmic artery, causing a decrease in blood flow to the ipsilateral retina. The most common source of these thromboemboli is an atherosclerotic carotid artery.[5]
However, a severely atherosclerotic carotid artery may also cause amaurosis fugax due to its stenosis of blood flow, leading to ischemia when the retina is exposed to bright light.[6] “Unilateral visual loss in bright light may indicate ipsilateral carotid artery occlusive disease and may reflect the inability of borderline circulation to sustain the increased retinal metabolic activity associated with exposure to bright light.”[7]
- Atherosclerotic ophthalmic artery: Will present similarly to an atherosclerotic internal carotid artery.
- Cardiac emboli: Emboli arising from the heart may also cause luminal obstruction of the retinal, ophthalmic, and/or ciliary arteries, causing a decrease in blood flow to the ipsilateral retina; examples being those arising due to (1) atrial fibrillation, (2) valvular abnormalities including post-rheumatic valvular disease, mitral valve prolapse, and a bicuspid aortic valve, and (3) atrial myxomas.
- Temporary vasospasm leading to decreased blood flow can be a cause of amaurosis fugax.[8][9] Generally, these episodes are brief, lasting no longer that five minutes,[10] and have been associated with exercise.[4][11] These vasospastic episodes are not restricted to young and healthy individuals. “Observations suggest that a systemic hemodynamic challenge provoke[s] the release of vasospastic substance in the rentinal vasculature of one eye.”[10]
- Giant cell arteritis: Giant cell arteritis can result in granulomatous inflammation within the central retinal artery and posterior ciliary arteries of eye, resulting in partial or complete occlusion, leading to decreased blood flow manifesting as amaurosis fugax. Commonly, amaurosis fugax caused by giant cell arteritis may be associated with jaw claudication and headache. However, it is also not uncommon for these patients to have no other symptoms.[12] One comprehensive review found a two to nineteen percent incidence of amaurosis fugax among these patients.[13]
- Malignant hypertension can cause ischemia of the optic nerve head leading to transient monocular visual loss.[26]
- Drug abuse-related intravascular emboli[2]
- Iatrogenic: Amaurosis fugax can present as a complication following carotid endarterectomy, carotid angiography, cardiac catheterization, and CABG surgery.[23]
Ocular origin
Ocular causes include:
- Iritis[27]
- Keratitis[18]
- Blepharitis[18]
- Optic disc drusen[23]
- Posterior vitreous detachment[18]
- Closed-angle glaucoma[28]
- Transient elevation of intraocular pressure[2][27]
- Intraocular hemorrhage[2]
- Coloboma[23]
- Myopia[23]
- Orbital hemangioma[29]
- Orbital osteoma[30]
- Keratoconjunctivitis sicca[23]
Neurologic origin
Neurological causes include:
- Compressive optic neuropathies[2][23]
- Papilledema: “The underlying mechanism for visual obscurations in all of these patients appear to be transient ischemia of the optic nerve head consequent to increased tissue pressure. Axonal swelling, intraneural masses, and increased influx of interstitial fluid may all contribute to increases in tissue pressure in the optic nerve head. The consequent reduction in perfusion pressure renders the small, low-pressure vessels that supply the optic nerve head vulnerable to compromise. Brief fluctuations in intracranial or systemic blood pressure may then result in transient loss of function in the eyes.”[31] Generally, this transient visual loss is also associated with a headache and optic disk swelling.
- Multiple Sclerosis can cause amaurosis fugax due to a unilateral conduction block, which is a result of demyelination and inflammation of the optic nerve, and “…possibly by defects in synaptic transmission and putative circulating blocking factors.”[32]
References
- ↑ Burde RM. “Amaurosis fugax. An overview.” J Clin Neuroophthalmol. 1989 Sep;9(3):185-9. PMID 2529279
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 The Amaurosis Fugax Study Group. “Current management of amaurosis fugax.” Stroke. 1990;21(2):201-208.
- ↑ Newman NJ. “Cerebrovascular disease.” Walsh & Hoyt’s Clinical Neuro-Ophthalmology. (Miller NR, Newman NJ, eds.) Vol 3. 5th ed. Baltimore, Williams & Wilkins; 1998:3420-3426.
- ↑ 4.0 4.1 “Exercise-Induced Vasospastic Amaurosis Fugax.” Arch Ophthalmol. 2002 February;120(2):220-222.
- ↑ Braat, Andries; Peter H. Hoogland, A.C. DeVries, J.C. Alexander de Mol VanOtterloo. “Amaurosis Fugax and Stenosis of the Ophthalmic Artery.” Vascular and Endovascular Surgery. 2001;35(2):141-142.
- ↑ Kaiboriboon K; Piriyawat P; Selhorst JB. “Light-induced amaurosis fugax.” Am J Ophthalmol. 2001 May;131(5):674-6. PMID 11336956.
- ↑ AU Furlan AJ; Whisnant JP; Kearns TP. “Unilateral visual loss in bright light. An unusual symptom of carotid artery occlusive disease.” Arch Neurol. 1979 Nov;36(11):675-6. PMID 508123.
- ↑ Ellenberger C Jr., Epstein AD. “Ocular complications of atherosclerosis: what do they mean?” Semin Neurol. 1986;6:185-193.
- ↑ Fisher M. “Transient monocular blindness associated with hemiplegia.” Arch Ophthalmol. 1952;47:167-203.
- ↑ 10.0 10.1 Burger, Stephen; robert Saul, John Selhorst, Stephen Thurston. “Transient monocular blindness caused by vasospasm.” The New England Journal of Medicine. 1991;325:870-873.
- ↑ Imes RK, Hoyt WF. “Exercise-induced transient visual events in young healthy adults.” J Clin Neuro Ophthalmol. 1989:9;9:178-180.
- ↑ AU Hayreh SS; Podhajsky PA; Zimmerman B. “Occult giant cell arteritis: ocular manifestations.” Am J Ophthalmol. 1998 Apr;125(4):521-6. PMID 9559738.
- ↑ Goodman BW Jr. “Temporal arteritis.” Am J Med. 1979;67:839-852.
- ↑ Giorgi, Afeltra, Gabrieli. “Transient visual symptoms in systemic lupus erthematosus and antiphospholipid syndrome.” Ocular Immunology and Inflammation. March 2001;9(1):49-57.
- ↑ Gold D, Feiner L, Henkind P. “Retinal arterial occlusive disease in systemic lupus erythematosus.” Arch Ophthalmol. 1977;95:1580-1585.
- ↑ Newman NM, Hoyt WF, Spencer WH. “Macula-sparing blackouts: clinical and pathologic investigations of intermittent choroidal vascular insufficiency in a case of periarteritis nodosa.” Arch Ophthalmol. 1974; 91:367-370.
- ↑ Schwartz ND, So YT, Hollander H, Allen S, Fye KH. “Eosinophilic vasculitis leading to amaurosis fugax in a patient with acquired immunodeficiency syndrome.” Arch Intern Med. 1986;146:2059-2060
- ↑ 18.0 18.1 18.2 18.3 18.4 Bacigalupi, Michael. “Amaurosis Fugax-A Clinical Review.” The Internet Journal of Allied Health Sciences and Practice. April 2006;4(2):1-6.
- ↑ Berdel, Theiss, Fink, Rastetter. “Peripheral arterial occlusion and amaurosis fugax as the first manifestation of polycythemia vera.” Journal Annals of Hematology. 1984;48(3):177-180.
- ↑ Mundall, Quintero, von Kaulla, Harmon, Austin. “Transient monocular blindness and increased platelet aggregability treated with aspirin.” Neurology. 1972;22:280-285.
- ↑ Smith. “Protein C deficiency: A cause of amaurosis fugax?” Neurol Neurosurg Psychiatry. 1987;50:361-362.
- ↑ Digre, Durcan, Branch, Jacobson, Varner, Baringer. “Amaurosis fugax associated with antiphospholipid antibodies.” Ann Neurol. 1989;25:228-232.
- ↑ 23.0 23.1 23.2 23.3 23.4 23.5 23.6 23.7 Digre, Kathleen. “Amaurosis Fugax and Not So Fugax—Vascular Disorders of the Eye.” Practical Viewing of the Optic Disc. Butterworth Heinemann: November 2002:269-344.
- ↑ Landi, Calloni, Sabbadini, Mannucci, Candelise. “Recurrent ischemic attacks in two young adults with lupus anticoagulants.” Stroke. 1983;14:377-379.
- ↑ Elias M, Eldor A. “Thromboembolism in patients with the ‘lupus’-type circulating anticoagulant.” arch Intern Med. 1984;144:510-515.
- ↑ Hayreh SS, Servais GE, Virdi PS. “Fundus lesions in malignant hypertension, V. hypertensive optic neuropathy.” Ophthalmology. 1986;93:74-87.
- ↑ 27.0 27.1 Sorensen PN. “Amaurosis fugax. A unselected material.” Acta Ophthalmol (Copenh). 1983 Aug;61(4):583-8. PMID: 6637419.
- ↑ Ravits J, Seybold M. “Transient monocular visual loss from narrow-angle glaucoma.” Arch Neurol. 1984;41:991-993.
- ↑ Brown GC, Shields JA. “Amaurosis fugax secondary to presumed cavernous hemangioma of the orbic.” Ann Ophthalmol. 1981;13:1205-12O9.
- ↑ Wilkes SR, Troutmann JC, DeSanto LW, Campbell RJ. “Osteoma. An unusual cause of amaurosis fugax.” Mayo Clin Proc. 1979;54:258-260.
- ↑ AU Hayreh SS; Podhajsky PA; Zimmerman B. “Transient visual obscurations with elevated optic discs.” Ann Neurol. 1984 Oct;16(4):489-94. PMID 6497356.
- ↑ AU Smith KJ; McDonald WI. “The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.” Philos Trans R Soc Lond B Biol Sci. 1999 October 29;354(1390):1649-73. PMID 10603618.
- ↑ Mattsson, Lundberg. “Characteristics and prevalence of transient visual disturbances indicative of migraine visual aura.” Cephalalgia. June 1999;19(5):447.
- ↑ Cologno, Torelli, Manzoni. “Transient vidual disturbances during migraine without aura attacks.” Headache. October 2002;42(9):930-933.
- ↑ Connor RCR. “Complicated migraine: A study of permanent neurological and visual defects caused by migraine.” Lancet. 1962;2:1072-1075.
- ↑ Carroll D. “Retinal migraine.” Headache. 1970;10:9-13.
- ↑ McDonald WI, Sanders MD. “Migraine complicated by ischemic papillopathy.” Lancet. 1971;2:521-523.
- ↑ Wolter JR, Burchfield WJ. “Ocular migraine in a young man resulting in unilateral transient blindness and retinal edema.” Pediatr Ophthalmol. 1971;8:173-176.
- ↑ Kline LB, Kelly CL. “Ocular migraine in a patient with cluster headaches.” Headache. 1980;20:253-257.
- ↑ Corbett JJ. “Neuro-ophthalmologic complications of migraine and cluster headaches.” Neurol Clin. 1983;l:973-995.
- ↑ 41.0 41.1 Hedges, Thomas. “The Terminology of Transient Visual Loss Due to Vascular Insufficiency.” Stroke. 1984; 15(5):907-908.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief: Marcelo R. Zacarkim, M.D. [2]
Overview
Amaurosis fugax is a symptom of carotid artery disease. It occurs when a piece of plaque in a carotid artery breaks off and travels to the retinal artery in the eye. The carotid arteries provide the main blood supply to the brain. They are located on each side of the neck under the jaw. Plaque is a hard substance that forms when fat, cholesterol[1], and other substances build up in the walls of arteries. Pieces of plaque can block blood flow. In people with amaurosis fugax, vision loss continues as long as the blood supply to the retinal artery is blocked. Atherosclerosis of the arteries in the neck is the main risk factor for this condition. Risk factors for atherosclerosis include heart disease, high cholesterol, smoking, diabetes, and high blood pressure[2].
Causes
Common Causes
Causes by Organ System
| Cardiovascular | Atherosclerosis, Blood coagulation disorders, Cardiac emboli, Cardiac failure, Carotid artery stenosis, Carotid occlusive disease, Carotid bifurcation thromboembolism, Central retinal vein occlusion, Decreased blood flow (ischemia) to the retina, Fatigue, Hollenhorst plaque(cholesterol embolus, Hyperlipidemia, Hypertension, Hypofibrinolysis, Hypoperfusion, Hypotension, Hypovolemia, Ischemic stroke, Local emboli (ipsilateral internal carotid artery, Malignant arterial hypertension, Preexisting asymmetric occlusive vascular disease, Retinal artery thrombosis, Retinal emboli, Retinal vein occlusion, Stroke, Vasospasm |
| Chemical / poisoning | No underlying causes |
| Dermatologic | No underlying causes |
| Drug Side Effect | Pramipexole |
| Ear Nose Throat | No underlying causes |
| Endocrine | Diabetes mellitus, Obesity |
| Environmental | No underlying causes |
| Gastroenterologic | No underlying causes |
| Genetic | No underlying causes |
| Hematologic | Thrombophilia |
| Iatrogenic | No underlying causes |
| Infectious Disease | No underlying causes |
| Musculoskeletal / Ortho | No underlying causes |
| Neurologic | Anterior ischemic optic neuropathy, Migraine aura, Neurologic disorder, Papilledema, Optic neuritis, Ischemic stroke, Retinal artery occlusion (RAO), Retinal vein occlusion |
| Nutritional / Metabolic | No underlying causes |
| Obstetric/Gynecologic | No underlying causes |
| Oncologic | No underlying causes |
| Opthalmologic | Blindness, Chiasm compression, Glaucoma, Ocular ischemic syndrome, Optic nerve, Sudden vision changes, Optic neuritis, Papilledema, Oculomotor disturbances |
| Overdose / Toxicity | No underlying causes |
| Psychiatric | Psychogenic |
| Pulmonary | No underlying causes |
| Renal / Electrolyte | Polyuria (frequent urination) |
| Rheum / Immune / Allergy | Inflammatory arteritis (Takayasu’s arteritis) |
| Sexual | No underlying causes |
| Trauma | No underlying causes |
| Urologic | No underlying causes |
| Dental | No underlying causes |
| Miscellaneous | Blood viscosity, Drug abuse, Idiopathic, Nonvascular ophthalmic disorder, Unexplained weight loss |
Causes in Alphabetical Order
- Blood coagulation disorders
- Blood viscosity
- Cardiac emboli (valve, mural thrombi, intracardiac tumor)
- Carotid bifurcation thromboembolism
- Carotid occlusive disease
- Central retinal artery occlusion[12]
- Chiasm compression
- Decreased blood flow (ischemia) to the retina
- Disease susceptibility
- Distal internal carotid artery atheroembolism
- Drug abuse-related (intravascular emboli)
- Extracranial arterial occlusive disease[12]
- Hollenhorst plaque (cholesterol embolus)[1]
- Hypofibrinolysis
- Hypoperfusion (from cardiac failure)[9]
- Inflammatory arteritis (Takayasu’s arteritis)[18]
- Irregular ulcerated lesion
- Local emboli (ipsilateral internal carotid artery)[19]
- Malignant arterial hypertension
- Neurologic disorder
- Nonvascular causes (hemorrhage, pressure, tumor, congenital)
- Nonvascular ophthalmic disorder
- Oculomotor disturbances
- Preexisting asymmetric occlusive vascular disease
- Reduced cardiac output (from a dysrhythmia)
- Retinal artery occlusion (RAO)[24]
- Retinal artery thrombosis
- Sudden vision changes
- Unexplained weight loss
- Very dry skin
References
- ↑ 1.0 1.1 1.2 1.3 Saric M, Kronzon I (2011). “Cholesterol embolization syndrome”. Curr. Opin. Cardiol. 26 (6): 472–9. doi:10.1097/HCO.0b013e32834b7fdd. PMID 21993354. Unknown parameter
|month=ignored (help) - ↑ 2.0 2.1 2.2 2.3 2.4 2.5 Tegos TJ, Kalodiki E, Daskalopoulou SS, Nicolaides AN (2000). “Stroke: epidemiology, clinical picture, and risk factors–Part I of III”. Angiology. 51 (10): 793–808. PMID 11108323. Unknown parameter
|month=ignored (help) - ↑ 3.0 3.1 3.2 Rahim A, Kumar P, Burns J, Sampath R (2012). “Isolated ocular cutaneous involvement in antiphospholipid syndrome”. Orbit. 31 (5): 367–9. doi:10.3109/01676830.2012.694554. PMID 22758382. Unknown parameter
|month=ignored (help) - ↑ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 4.7 Rozegnał-Madej A, Bielecka E, Swiech-Zubilewicz A, Zarnowski T, Karakuła W, Zubilewicz T (2012). “[Ophthalmological complications associated with clinically significant carotid stenosis]”. Klin Oczna (in Polish). 114 (1): 57–62. PMID 22783748.
- ↑ 5.0 5.1 5.2 Owen DR, Shalhoub J, Miller S; et al. (2010). “Inflammation within carotid atherosclerotic plaque: assessment with late-phase contrast-enhanced US”. Radiology. 255 (2): 638–44. doi:10.1148/radiol.10091365. PMID 20413774. Unknown parameter
|month=ignored (help) - ↑ 6.0 6.1 6.2 Alba MA, Mena-Madrazo JA, Reyes E, Flores-Suárez LF (2012). “Giant cell arteritis in Mexican patients”. J Clin Rheumatol. 18 (1): 1–7. doi:10.1097/RHU.0b013e31823e2e35. PMID 22157266. Unknown parameter
|month=ignored (help) - ↑ 7.0 7.1 Medrano-Martínez V, Sempere AP, Mola S, Flores-Ruiz JJ, Vázquez-Suárez JC (2002). “[Amaurosis fugax as the sole manifestation of a dural arteriovenous fistula]”. Rev Neurol (in Spanish; Castilian). 35 (4): 325–7. PMID 12235561.
- ↑ 8.0 8.1 Huwez F, Umasankar U, Casswell E, Menon J, Gadi N (2011). “Sudden loss of vision in a patient with significant ipsilateral internal carotid disease”. BMJ Case Rep. 2011. doi:10.1136/bcr.08.2011.4725. PMID 22669766.
- ↑ 9.0 9.1 9.2 9.3 Tomaschütz L, Dos Santos M, Schill J, Palm F, Grau A (2012). “Recurrent amaurosis fugax in a patient after stanford type a dissection depending on blood pressure and haemoglobin level”. Case Rep Vasc Med. 2012: 254204. doi:10.1155/2012/254204. PMC 3502825. PMID 23198268.
- ↑ 10.0 10.1 Glueck CJ, Hutchins RK, Jurantee J, Khan Z, Wang P (2012). “Thrombophilia and retinal vascular occlusion”. Clin Ophthalmol. 6: 1377–84. doi:10.2147/OPTH.S34627. PMC 3437951. PMID 22969282.
- ↑ Cugati S, Wang JJ, Rochtchina E, Mitchell P (2006). “Ten-year incidence of retinal emboli in an older population”. Stroke. 37 (3): 908–10. doi:10.1161/01.STR.0000204118.87477.46. PMID 16439697. Unknown parameter
|month=ignored (help) - ↑ 12.0 12.1 Ahuja RM, Chaturvedi S, Eliott D, Joshi N, Puklin JE, Abrams GW (1999). “Mechanisms of retinal arterial occlusive disease in African American and Caucasian patients”. Stroke. 30 (8): 1506–9. PMID 10436091. Unknown parameter
|month=ignored (help) - ↑ Hurwitz BJ, Heyman A, Wilkinson WE, Haynes CS, Utley CM (1985). “Comparison of amaurosis fugax and transient cerebral ischemia: a prospective clinical and arteriographic study”. Ann. Neurol. 18 (6): 698–704. doi:10.1002/ana.410180612. PMID 4083852. Unknown parameter
|month=ignored (help) - ↑ 14.0 14.1 14.2 Paul NL, Simoni M, Rothwell PM (2013). “Transient isolated brainstem symptoms preceding posterior circulation stroke: a population-based study”. Lancet Neurol. 12 (1): 65–71. doi:10.1016/S1474-4422(12)70299-5. PMC 3530272. PMID 23206553. Unknown parameter
|month=ignored (help) - ↑ Hayreh SS, Podhajsky PA, Zimmerman B (1998). “Ocular manifestations of giant cell arteritis”. Am. J. Ophthalmol. 125 (4): 509–20. PMID 9559737. Unknown parameter
|month=ignored (help) - ↑ Hayreh SS, Podhajsky PA, Zimmerman B (1998). “Occult giant cell arteritis: ocular manifestations”. Am. J. Ophthalmol. 125 (4): 521–6. PMID 9559738. Unknown parameter
|month=ignored (help) - ↑ 17.0 17.1 Khan AO (2006). “Severe psychogenic visual loss in a girl with siblings blinded from congenital glaucoma”. J AAPOS. 10 (4): 373–4. doi:10.1016/j.jaapos.2006.01.216. PMID 16935241. Unknown parameter
|month=ignored (help) - ↑ Nazzal MD, Agko M, Zingale K, Hamdan M, Higgins JA, Clark P (2011). “A unique presentation of Takayasu’s arteritis in a 39-year-old male with chest pain, vertigo, and blindness”. J. Vasc. Surg. 54 (2): 529–32. doi:10.1016/j.jvs.2010.12.059. PMID 21397438. Unknown parameter
|month=ignored (help) - ↑ 19.0 19.1 Bishara SA, Estrin I, Rand WJ (1990). “Immediate contralateral amaurosis after retrobulbar anesthesia”. Ann Ophthalmol. 22 (2): 63–5. PMID 2316954. Unknown parameter
|month=ignored (help) - ↑ 20.0 20.1 Coroi M, Bontas E, Visan R, Defranceschi M, Cioranu CD (2007). “Ocular migraine and antiphospholipid antibodies–where we stand?”. Oftalmologia. 51 (3): 8–15. PMID 18064948.
- ↑ Roşca T (2008). “[Methods of prevention of ischemic cerebral damages in patients with antiphospholipid antibodies]”. Oftalmologia (in Romanian). 52 (2): 72–6. PMID 19065918.
- ↑ 22.0 22.1 Awad AM, Estephan B, Warnack W, Stüve O (2009). “Optic neuritis presenting with amaurosis fugax”. J. Neurol. 256 (12): 2100–3. doi:10.1007/s00415-009-5302-4. PMID 19727900. Unknown parameter
|month=ignored (help) - ↑ Lord RS (1990). “Transient monocular blindness”. Aust N Z J Ophthalmol. 18 (3): 299–305. PMID 2261177. Unknown parameter
|month=ignored (help) - ↑ Mead GE, Lewis SC, Wardlaw JM, Dennis MS (2002). “Comparison of risk factors in patients with transient and prolonged eye and brain ischemic syndromes”. Stroke. 33 (10): 2383–90. PMID 12364725. Unknown parameter
|month=ignored (help) - ↑ Wang JJ, Cugati S, Knudtson MD; et al. (2006). “Retinal arteriolar emboli and long-term mortality: pooled data analysis from two older populations”. Stroke. 37 (7): 1833–6. doi:10.1161/01.STR.0000226929.23297.75. PMID 16741179. Unknown parameter
|month=ignored (help)
Differentiating Amaurosis fugax from other Diseases
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
Overview
Leber’s congenital amaurosis is an inherited disease resulting in severe vision loss or blindness that was first described by Theodore Leber in the 19th century. Amaurosis can also occur in ruminants suffering from a vitamin B1 (Thiamin) deficiency due to Thiamine-Related Cerebrocortical Necrosis (CCN).
References
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
Overview
In a small minority of those who experience amaurosis, stroke or vision loss has resulted. Diabetes, hypertension and smoking are factors known to increase the risks of suffering this condition. It also can be the result of surgical repair to the mitral valve, when very small emboli may break away from the site of the repair, while the patient’s tissue grows to cover the plastic annuloplasty band.
References
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Diagnosis
Diagnosis
Diagnostic Evaluation | History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
